Silicon Canals
TRENDING
  • Mobility
  • AI
  • FinTech
  • Software & SaaS
No Result
View All Result
  • Home
  • News
    • COVID-19
    • Startups
    • Scaleups
    • FinTech
    • AI and chatbots
    • Travel & Mobility
    • Software & SaaS
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
  • Features
    • Promoted content
    • How-to
    • Knowledge & Insights
    • Guest Contributions
    • Scaling-up in Europe
  • Amsterdampartner
  • Events
  • Newsletter
  • Jobs
  • About
    • Partner with Silicon Canals
    • Team
    • Contact
  • Home
  • News
    • COVID-19
    • Startups
    • Scaleups
    • FinTech
    • AI and chatbots
    • Travel & Mobility
    • Software & SaaS
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
  • Features
    • Promoted content
    • How-to
    • Knowledge & Insights
    • Guest Contributions
    • Scaling-up in Europe
  • Amsterdampartner
  • Events
  • Newsletter
  • Jobs
  • About
    • Partner with Silicon Canals
    • Team
    • Contact
No Result
View All Result
Silicon Canals
No Result
View All Result

This Eindhoven-based startup is developing a new bioelectronic therapy for migraines; raises €26M

Editorial team by Editorial team
September 23, 2020
in News, (Crowd)funding, Featured post, Health & Medtech, Startups
0
This Eindhoven-based startup is developing a new bioelectronic therapy for migraines; raises €26M
55
SHARES
LinkedInTwitterWhatsAppFacebook

Migraine is the first cause of disability in under 50s, affecting one out of seven people, predominantly women. People with migraine experience episodes of throbbing, pulsating pain, sometimes accompanied by nausea, vomiting, and sensitivity to light that may last from a few hours to a few days.

More than 5% of patients suffer from chronic migraine, where they experience migraines for an average of 22 days per month.

 - Partner content -
Cost of software - The Software house
The cost of building software
Marek Gajda, CTO of The Software House, shares his insights on building high-quality...Show More
Marek Gajda, CTO of The Software House, shares his insights on building high-quality software. Show Less
Read more

Neurostimulation has been proven as an effective treatment in chronic migraine, however, as of now, there are no approved implantable devices. 

While traditional neurostimulation systems are not designed to be compatible with the anatomy of the head, a neurostimulation platform company Salvia BioElectronics is developing very thin bio-electronic foils that can be placed under the skin in a minimally invasive procedure.

Raised funding

Eindhoven-based Salvia BioElectronics – a company that targets chronic migraine, has raised €26M in its Series A round of funding led by Panakes Partners, INKEF Capital, and SHS Gesellschaft fur Beteiligungsmanagement. Besides, BOM Capital, Thuja Capital, and Dolby Ventures also participated in this round.

Diana Saraceni, founder and managing partner at Panakes Partners; Roel Bulthuis, managing partner at INKEF Capital; and Sascha Alilovic, managing partner of SHS Gesellschaft fur Beteiligungsmanagement will join the Board of Directors.

The raised capital will be utilised in developing a unique neuromodulation technology that is capable of addressing known neural targets in chronic migraine and provide its therapy to those suffering from debilitating headaches.

A €5M ‘innovation loan’ from the Rijksdienst Voor Ondernemend Nederland (RVO, part of the Dutch Ministry of Economic Affairs) also has been provided in this round.

Save yourself a headache

The name Salvia is derived from the Latin word salvere, which means “to stay healthy”. In addition, the Salvia-plant has been used to treat headaches, pain, and mental disorders over centuries, according to the company. 

Founded in 2017, Salvia BioElectronics is a Dutch startup active in the emerging field of bioelectronics. It was founded by neuromodulation industry experts with the ambition to develop a bioelectronics therapy for people suffering from chronic migraine, without any medications and side-effects. Building on research around known neural targets in migraine, the startup is working to develop the right form factor for stimulation that is effective, safe, and affordable.

The Salvia team consists of experienced entrepreneurs, engineers and scientists with diverse professional backgrounds and proven track-record throughout the medical device industry (Sapiens, Medtronic, Philips, St Jude, BioSensors International, Kyphon, etc).

Reportedly, the product has not yet hit the market as it needs to undergo extensive testing. Besides, the implant is yet to be approved.

Image credit: Salvia Bioelectronics

close

Want to stay on top of the latest rounds, coolest tech and hottest startups?

Subscribe to our free, daily news blast and stay up-to-date!

Check your inbox or spam folder to confirm your subscription.

 - Partner content -
Nebula CTO Andre Witte
Cloud spend management 😱
Tracking cloud spend can be tricky. Learn from Nebula's CTO Andre Witte how to keep the...Show More
Tracking cloud spend can be tricky. Learn from Nebula's CTO Andre Witte how to keep the costs at bay in 2021. Show Less
Read more
Tags: fundingmedtech
Share4Tweet14SendShare22

Partner content | Work with us

Future of coding: CTOs discuss low-code versus custom code software development for their business

Why now is the perfect time to start hiring for 2021

SaaS sales in 2021: 9 predictions from an industry expert

Diversity in hiring for SaaS: the often overlooked topic of ageism

Boost your scale-up’s growth by outsourcing to these top Eastern European software development companies

Subscribe to our daily newsletter

Check your inbox or spam folder to confirm your subscription.

Breaking news from Amsterdam | Partner

Amsterdam-based Creative Fabrica raises €5.76M Series A to change the way people consume digital assets

Here’s how Amsterdam-based Virtuagym helps gyms, fitness providers during lockdown

Amsterdam-based soft-skill scaleup Lepaya enters Sweden; here’s why

9 promising sustainable startups from Amsterdam to watch in 2021

Advertisement

Trending

Amsterdam
Amsterdam

9 promising sustainable startups from Amsterdam to watch in 2021

January 20, 2021
BUX
News

The crypto platform of Amsterdam fintech BUX witnesses “explosive growth” as Bitcoin remains popular

January 22, 2021
Dutch Scaleup
Amsterdam

Meet the 10 Dutch scaleups selected by Amsterdam-based Techleap.nl for Rise Programme 2021

January 20, 2021
  • About Silicon Canals
  • Partner with Silicon Canals
  • Contact us
  • Newsletter
  • Disclaimer
  • Privacy policy
  • Terms & Conditions Silicon Canals

Silicon Canals 2014-2020 | Website: Bright Idiots

No Result
View All Result
  • Home
  • News
    • COVID-19
    • Startups
    • Scaleups
    • FinTech
    • AI and chatbots
    • Travel & Mobility
    • Software & SaaS
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
  • Features
    • Promoted content
    • How-to
    • Knowledge & Insights
    • Guest Contributions
    • Scaling-up in Europe
  • Amsterdam
  • Events
  • Newsletter
  • Jobs
  • About
    • Partner with Silicon Canals
    • Team
    • Contact

Silicon Canals 2014-2020 | Website: Bright Idiots

X

This website uses cookies to ensure the best possible experience. We may share this information with our advertising and analytics partners. By clicking 'Accept', you agree to our use of cookies and similar technologies. More info